Login/Sign Up
CIDNAVIR 75MG/ML INJ
CIDNAVIR 75MG/ML INJ is used in the treatment of cytomegalovirus (CMV) retinitis. It contains Cidofovir, which works by inhibiting the CMV polymerase enzyme responsible for viral DNA synthesis. It works by slowing the growth of the cytomegalovirus. Thus, it helps treat Cytomegalovirus (CMV) retinitis. This medicine is contraindicated in patients with renal insufficiency and patients who cannot receive probenecid or other sulfa-containing products. This medicine should not be used for conditions other than CMV retinitis.
₹47548.5*
MRP ₹57986
18% off
₹49288.1*
MRP ₹57986
15% CB
₹8697.9 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
CIDNAVIR 75MG/ML INJ is an antiviral medicine used in the treatment of cytomegalovirus (CMV) retinitis. Cytomegalovirus (CMV) retinitis is a viral infection that affects the retina of the eye caused by a virus called Cytomegalovirus (CMV), especially in AIDS patients. It is a serious infection that can lead to blindness. CIDNAVIR 75MG/ML INJ is used in combination with oral probenecid.
CIDNAVIR 75MG/ML INJ contains Cidofovir, which works by inhibiting the CMV polymerase enzyme responsible for viral DNA synthesis. It works by slowing the growth of the cytomegalovirus. Thus, it helps treat Cytomegalovirus (CMV) retinitis.
CIDNAVIR 75MG/ML INJ may cause certain side effects such as nausea, vomiting, headache, hair loss, rash, weakness, fever, inflammation of the eye, shortness of breath, diarrhoea, chills, and pain at the injection site. These side effects may not occur in every patient using this medication and gradually resolve over time. If the side effects persist longer or worsen, please inform your doctor. A healthcare professional will administer CIDNAVIR 75MG/ML INJ; hence, do not self-administer.
CIDNAVIR 75MG/ML INJ should be avoided if you are allergic to it. This medicine is contraindicated in patients with renal insufficiency and patients who cannot receive probenecid or other sulfa-containing products. This medicine should not be used for conditions other than CMV retinitis. Let your doctor know about your complete medical and medication history to rule out any interactions. Inform your doctor if you have a weakened immune system, an electrolyte imbalance, diabetes, and liver or kidney diseases before starting the use of CIDNAVIR 75MG/ML INJ. CIDNAVIR 75MG/ML INJ is not recommended for use in pregnant and breastfeeding women.
CIDNAVIR 75MG/ML INJ treats viral infection of the eye caused by Cytomegalovirus (CMV) retinitis. CIDNAVIR 75MG/ML INJ consists of Cidofovir, which works by inhibiting the CMV polymerase enzyme responsible for viral DNA synthesis. It helps kill the virus and eventually stop the growth of the cytomegalovirus. Thus, helps to treat Cytomegalovirus (CMV) retinitis. This medicine is only used in treating CMV retinitis but is not used for other conditions. It does not help in treating HIV infection.
CIDNAVIR 75MG/ML INJ should be avoided if you are allergic to it. Let your doctor know about your medical history and medication history to rule out any interactions. This medicine is contraindicated in patients with renal insufficiency, patients who cannot receive probenecid or other sulfa-containing products, and the use of CIDNAVIR 75MG/ML INJ in conditions other than CMV retinitis. Inform your doctor if you have a weakened immune system, an electrolyte imbalance, diabetes, and liver or kidney diseases before starting CIDNAVIR 75MG/ML INJ. CIDNAVIR 75MG/ML INJ is not recommended for use in pregnant and breastfeeding women. Hence, inform your doctor before starting CIDNAVIR 75MG/ML INJ. CIDNAVIR 75MG/ML INJ may cause nephrotoxicity, haematological toxicity, decreased intraocular pressure, and metabolic acidosis in some patients. Hence, patients should be monitored carefully for any changes during the treatment. CIDNAVIR 75MG/ML INJ is not recommended for use in children below 16 years of age as the safety and efficacy are not established. Avoid driving and operating machines, as it can cause fatigue and dizziness.
Drug-Drug Interactions: CIDNAVIR 75MG/ML INJ may interact with antiviral drugs (Zidovudine, adefovir, tenofovir), anti-gout medicines (Probenecid), nephrotoxic drugs (foscarnet, amikacin, amphotericin B, vancomycin, gentamycin, tobramycin, pentamidine, ibuprofen, naproxen), etc.
Drug-Food Interactions: No drug-food interactions were found.
Drug-Disease Interactions: CIDNAVIR 75MG/ML INJ may have interactions with liver disease, kidney dysfunction, blood disorders, cancer patients, and diabetes.
Cytomegalovirus (CMV) retinitis: This is an eye infection caused when Cytomegalovirus (CMV) affects the retina (light-sensing nerve layer) of the eye, which can lead to blindness or eye problems. It mainly occurs in weak immune patients, such as AIDS (Acquired immune deficiency syndrome). Symptoms include eye pain, tearing, redness, blurred vision, blind spots and visual disturbances.
Alcohol
Consult your doctor
There is limited information on how alcohol consumption affects CIDNAVIR 75MG/ML INJ. Please consult your doctor.
Pregnancy
Unsafe
CIDNAVIR 75MG/ML INJ may cause fetal toxicity and impairment of fertility in males and females. Hence, inform your doctor if you are pregnant before receiving CIDNAVIR 75MG/ML INJ.
Breast Feeding
Unsafe
CIDNAVIR 75MG/ML INJ is not recommended for use in nursing mothers as it can cause serious side effects to newborn infants. Hence, inform your doctor if you are breastfeeding.
Driving
Unsafe
CIDNAVIR 75MG/ML INJ may cause fatigue and drowsiness. Hence, do not drive or operate machinery that requires mental alertness until you are not alert.
Liver
Caution
Inform your doctor if you have any history of liver diseases or hepatic impairment before receiving CIDNAVIR 75MG/ML INJ. Your doctor will advise this medicine only if the benefits outweigh the risks.
Kidney
Caution
CIDNAVIR 75MG/ML INJ is known to cause kidney damage. Hence, inform your doctor if you have any history of kidney problems before receiving CIDNAVIR 75MG/ML INJ. This medicine is contraindicated in patients with severe renal disease or renal insufficiency.
Children
Unsafe
The use of CIDNAVIR 75MG/ML INJ is not recommended for children below 18 years of age as the safety and efficacy data are not established.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.